These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1351026)

  • 1. [Interactions of theophylline and H2 receptor antagonists. Interaction modes--clinical relevance].
    Beier W; Kaukel E
    Fortschr Med; 1992 Mar; 110(9):158-60. PubMed ID: 1351026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The status of H2-blocker therapy today].
    Rameis H
    Wien Med Wochenschr; 1992; 142(18):398-405. PubMed ID: 1362029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine-theophylline interaction: report of four patients.
    Bauman JH; Kimelblatt BJ; Caraccio TR; Silverman HM; Simon GI; Beck GJ
    Ann Allergy; 1982 Feb; 48(2):100-2. PubMed ID: 6121526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The interaction potential of H2 receptor antagonists. A short current review].
    Klotz U; Kroemer HK
    Fortschr Med; 1991 Sep; 109(28):574-6. PubMed ID: 1684557
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined administration of controlled release theophylline and ranitidine: a 53-day controlled survey in patients with chronic obstructive lung disease (COLD) and peptic disease.
    Dal Negro R; Turco P; Pomari C; Trevisan F; De Conti F; Cordaro CI
    Br J Clin Pract; 1987 Nov; 41(11):1004-8. PubMed ID: 3504314
    [No Abstract]   [Full Text] [Related]  

  • 6. [H2 receptor antagonists in the therapy of peptic ulcer disease].
    Dammann HG; Dau B; Dreyer M; Müller P; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():136-45. PubMed ID: 2889298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Famotidine and theophylline pharmacokinetics. An unexpected cimetidine-like interaction in patients with chronic obstructive pulmonary disease.
    Dal Negro R; Pomari C; Turco P
    Clin Pharmacokinet; 1993 Mar; 24(3):255-8. PubMed ID: 8462230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine H2-receptor antagonists.
    Keithley JK
    Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is important in treating elderly with H2 receptor antagonists].
    Kurosawa S
    Nihon Rinsho; 2002 Aug; 60(8):1613-7. PubMed ID: 12187760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H2-receptor antagonists and chronic theophylline toxicity.
    Alterman P; Spiegel D; Feldman J; Yaretzky A
    Am Fam Physician; 1996 Oct; 54(5):1473, 1477. PubMed ID: 8857772
    [No Abstract]   [Full Text] [Related]  

  • 11. [What is the role of H2 receptor blockers today in ulcer therapy?].
    Creutzfeldt W
    Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases].
    Grebnev AL; Miagkova LP; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):23-7. PubMed ID: 1676772
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W
    J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for peptic ulcer disease and GERD.
    Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N; Miwa T
    Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs for peptic ulcers.
    Treat Guidel Med Lett; 2004 Feb; 2(18):9-12. PubMed ID: 15529109
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on peptic ulcer drugs.
    Aronson B
    Am J Nurs; 1998 Jan; 98(1):41-6. PubMed ID: 9455332
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E; Foschi D; Belloli P; Montorsi F; Marchetti V; Mariscotti C; Diamantini S
    Minerva Dietol Gastroenterol; 1989; 35(1):1-6. PubMed ID: 2566959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
    Grigor'ev PIa; Isakov VA
    Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.